These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1322257

  • 1. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
    Lawrence RH, Sorrelli TC.
    Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
    [Abstract] [Full Text] [Related]

  • 2. Human monocyte and polymorphonuclear leukocyte chemotactic and chemokinetic responses to leukotriene B4 and FMLP.
    Ternowitz T, Herlin T, Fogh K.
    Acta Pathol Microbiol Immunol Scand C; 1987 Apr; 95(2):47-54. PubMed ID: 3037849
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 4. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
    Loike JD, el Khoury J, Cao L, Richards CP, Rascoff H, Mandeville JT, Maxfield FR, Silverstein SC.
    J Exp Med; 1995 May 01; 181(5):1763-72. PubMed ID: 7722453
    [Abstract] [Full Text] [Related]

  • 5. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T, Fogh K, Kragballe K.
    Skin Pharmacol; 1988 May 01; 1(2):93-9. PubMed ID: 2856182
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT.
    J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083
    [Abstract] [Full Text] [Related]

  • 7. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE, Zanolari B, Springer MS, Guindon Y, Zamboni R, Lau CK, Rokach J.
    Prostaglandins; 1983 Feb 15; 25(2):281-9. PubMed ID: 6304818
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
    Dos Santos C, Davidson D.
    Pediatr Res; 1993 Mar 15; 33(3):242-6. PubMed ID: 8384710
    [Abstract] [Full Text] [Related]

  • 9. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration.
    Nohgawa M, Sasada M, Maeda A, Asagoe K, Harakawa N, Takano K, Yamamoto K, Okuma M.
    J Leukoc Biol; 1997 Aug 15; 62(2):203-9. PubMed ID: 9261334
    [Abstract] [Full Text] [Related]

  • 10. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
    Jubiz W.
    Biochem Biophys Res Commun; 1983 Feb 10; 110(3):842-50. PubMed ID: 6301465
    [Abstract] [Full Text] [Related]

  • 11. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response.
    Kreisle RA, Parker CW, Griffin GL, Senior RM, Stenson WF.
    J Immunol; 1985 May 10; 134(5):3356-63. PubMed ID: 2984287
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L, McCall CE, Bass DA, McPhail LC.
    J Immunol; 1987 Nov 01; 139(9):3055-61. PubMed ID: 2822802
    [Abstract] [Full Text] [Related]

  • 13. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS, Keith RH, Villani-Price D, Haack RA, Djuric SW.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1493-8. PubMed ID: 8138959
    [Abstract] [Full Text] [Related]

  • 14. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G, Schwarzer C.
    J Biolumin Chemilumin; 1991 Mar 01; 6(3):159-67. PubMed ID: 1660670
    [Abstract] [Full Text] [Related]

  • 15. Depressed leukotriene B4 chemotactic response of neutrophils from localized juvenile periodontitis patients.
    Offenbacher S, Scott SS, Odle BM, Wilson-Burrows C, Van Dyke TE.
    J Periodontol; 1987 Sep 01; 58(9):602-6. PubMed ID: 2821216
    [Abstract] [Full Text] [Related]

  • 16. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW.
    Clin Sci (Lond); 1989 Aug 01; 77(2):195-203. PubMed ID: 2548801
    [Abstract] [Full Text] [Related]

  • 17. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
    Kankaanranta H, Moilanen E, Vapaatalo H.
    Inflammation; 1991 Apr 01; 15(2):137-43. PubMed ID: 1649132
    [Abstract] [Full Text] [Related]

  • 18. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4.
    Lawrence R, Sorrell T.
    Lancet; 1993 Aug 21; 342(8869):465-9. PubMed ID: 8102430
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr 21; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 20. Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia.
    Reilly IA, Knapp HR, Fitzgerald GA.
    J Clin Pathol; 1988 Nov 21; 41(11):1163-7. PubMed ID: 2850300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.